How to appeal a Highmark orthopedics & sports medicine denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Highmark-specific note: Operates BCBS in PA (western), WV, DE, NY (western). Owns Allegheny Health Network.

What Highmark's policy requires for orthopedics & sports medicine

Cited policy: BCBS Specialty Surgery — MACI Autologous Chondrocyte Implantation

Symptomatic full-thickness ICRS grade 3-4 cartilage lesion. Lesion >=2 cm². Failed prior cartilage procedure (microfracture / OATS) OR large primary lesion. BMI <35. Intact menisci / aligned limb (or concomitant osteotomy). Age 18-55.

How Highmark denies orthopedics & sports medicine — and how to counter it

Where Highmark pushes back: 1) Try microfracture first; 2) Lesion size insufficient; 3) Mechanical alignment not documented.

Counter-arguments that hold up: SUMMIT trial Saris AJSM 2014 + Brittberg 2018 5-yr — MACI superior at >=3 cm². FDA approval Dec 13, 2016 (BLA 125603). Label includes prior failed cartilage repair. ICRS 2016 algorithm. Submit diagnostic arthroscopy report or high-res MRI mapping + mechanical alignment X-rays (long-leg standing) + meniscal status. Knutsen JBJS 14-yr follow-up.

What Highmark typically denies for orthopedics & sports medicine

Across Highmark's commercial and Medicare books, denials cluster around a small number of patterns. For orthopedics & sports medicine, expect:

• Prior auth on biologics
• PA on advanced imaging
• OON balance bills

Treatments most often denied in this category

These are the orthopedics & sports medicine treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Total knee replacement
• Total hip replacement
• Shoulder replacement
• Ankle replacement
• Partial knee (UKA)
• ACL reconstruction

How to submit the appeal to Highmark

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Highmark cited in the denial.
3. File the appeal through Highmark's portal (members: https://www.highmark.com ; providers: https://www.highmark.com/provider). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In PA, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Highmark's prior-authorization criteria by drug: Highmark PA criteria on ApprovalHelp.